00

Daan Gene Co LtdSHE 002030 Stock Report

Last reporting period 31 Mar, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

1.056

Small

Exchange

XSHE - Shenzhen Stock Exchange

002030.SZ Stock Analysis

00

Uncovered

Daan Gene Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

1.056

Dividend yield

0.25 %

Shares outstanding

1 413.27 B

Daan Gene Co., Ltd. engages in the research, development, production and sales of clinical testing reagents and instruments; and provision of clinical laboratory services. The company is headquartered in Guangzhou, Guangdong and currently employs 2,713 full-time employees. The company went IPO on 2004-08-09. The Company’s main products include fluorescence quantitative polymerase chain reaction (PCR) series, public health series, time-resolved series and enzyme-linked immunization series. The firm also provides independent medical clinical laboratory testing services. The firm operates its business in domestic market.

View Section: Eyestock Rating